“We will be able to provide preliminary data only in mid-November,” RIA Novosti Gintsburg quotes.
Earlier, the Russian direct investment fund sent applications to the World Health Organization for an accelerated registration procedure for the COVID-19 vaccine Sputnik V.
Inna Dolzhikova, the head of the laboratory of the State Collection of Viruses at the Gamaleya Center, spoke to URA.RU about the Sputnik V vaccine.